Abstract

W
Other articles in this issue address several different aspects of the host response to viral infections. Painter et al. have analyzed the humoral response to influenza A virus infection in older adults. Using a B cell ELISPOT assay to measure virus-specific B cells after influenza vaccination in older adults, the authors have characterized kinetics of the response in detail. The results suggest that the B cell ELISPOT assay is an excellent tool to profile and monitor the humoral immune responses in older subjects after influenza vaccination. An article by Nazmi and colleagues investigates the role of neural stem/progenitor cells (NSPCs) in the immune response. Using a model of Japanese encephalitis virus (JEV), the authors show that NSPCs regulate excessive inflammation in the CNS by converting encephalitogenic T-cells into CD4+CD25+FOXP3+regulatory T cells. This conversion was dependent on direct contact between the T-cells and the NSPCs. The study offers new insights into the interaction between CNS-infiltrating encephalitogenic T-cells and NSPCs during viral encephalitis. Seo and Hahm have investigated the effect of a sphingosine analog, AAL-R, on the activation of dendritic cells (DCs) infected with lymphocytic choriomeningitis virus (LCMV). Interestingly, AAL-R increased type I IFN production from DCs infected with LCMV, suggesting that the sphingosine analog acted directly on DCs to promote defensive responses via type I IFN signaling.
Two studies focus on technical issues related to vaccination and protein production. Ferreira de Lima Neto and colleagues have investigated the effect of high hydrostatic pressure (HHP) on tobacco mosaic virus (TMV). Using a mouse model of infection, the authors show that HHP significantly altered the recognition epitopes when compared to the native virus. Importantly, different cleavage sites were exposed after treatments and this was confirmed by epitope mapping studies. The data suggest that HHP can be used to prepare whole virus particles that are highly immunogenic and still retain neutralizing epitopes, in addition to unmasking other epitopes that are normally unavailable in the native virus before treatment. Abdel-Moneim et al. have engineered dual expression vectors containing the N and S proteins of avian infectious bronchitis virus. The genes are under the control of human and murine cytomegalovirus immediate-early enhancer/promoter elements in combination with the baculoviral polyhedrin and p10 promoters to allow for simultaneous expression in both vertebrate and insect cells. The studies show that the dual expression cassettes yielded high levels of protein from both transcription units. These vectors will be invaluable for the production of large quantities of purified proteins.
